We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Quality-adjusted survival analysis shows improved outcomes with cilta-cel in multiple myeloma, suggesting potential benefits over standard care.
No takes yet. Share an insight, caveat, or question.
Sidana et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: